Skip To The Main Content

Browse these ideas available for licensing that have the potential to improve lives while creating jobs to support and grow the region.


All ideas
are listed as non-confidential technical summaries.

Ideas were generated by academic institutions, entrepreneurs, and corporations.

Ideas from our research institution partners can be reviewed by following the web links to their database.

Highlighted ideas from our partners are featured separately and organized by category. All listings are updated as new technology opportunities become available..

For assistance in connecting with, or attaining further information on any of these technologies, please contact us.

Novel Bone Graft Substitute

Researchers have developed a novel method of inducing stem cell differentiation towards an osteoblast bone cell lineage. Inducing a bone graft to effectively immobilize a joint through bone formation requires that the graft engage in osteoinduction in order to create mature bone cells. This has typically been accomplished through the use of bone growth factors present in bone morphogenic proteins, demineralized bone matrix, and autograft and allograft bone. The present technology utilizes a newly-developed material that provides a better, cheaper, and more cost-effective alternative to these traditional techniques. Better bone grafting materials could significantly affect the cost and effectiveness of a wide range of common procedures.

Each year in the United States, approximately 300,000 patients suffer nonunions resulting from incomplete healing after fractures. The total cost, including surgery, doctor visits, quality of life and missed work, amounts to between $7 billion and $17 billion according to Medscape. Bone grafts are the current gold standard for treating nonunions, but problems such as donor scarcity, supply limitation, donor site morbidity, pathogen transfer, and immunte-mediated rejection limits its application for bone defects. A major challenge facing this field is the development of a bone graft substitute which is capable of promoting differentiation of endogenous stem cells down the osteoblastic lineage.

POTENTIAL COMMERCIAL APPLICATION(S):
  • Spinal Fusion
  • Persistent Nonunions
  • Osteogenesis (Bone Healing)


Additional Details

Owner

University of Missouri

Intellectual Property Protection

Unknown



Interested? Request More Information